eBook

Your Guide To Efficiently Develop Antibody-Based Therapeutics

smartmockups_l9zw07iq

In the “Quality by Design” approach for monoclonal antibody (mAb)-based therapeutics development, stability characterization—the probability of a protein unfolding—is performed to ensure that structure and function are preserved throughout development and manufacturing.

Therefore, stability characterization assays are pivotal to develop and determine the best formulations and storage conditions for each therapeutic.

If you are interested in biologics characterization, or tasked with performing storage and formulation studies, read this eBook to learn about:
  • Various methods to measure the stability of biotherapeutics
  • The ins and outs of monoclonal antibody formulation
  • A typical timeline for Investigational New Drug (IND) and Biological License Application (BLA) filings
  • Storage conditions and how they affect mAb stability


If you are interested in biologics characterization, or tasked with performing storage and formulation studies, read this eBook to learn about:

  • Various methods to measure the stability of biotherapeutics
  • The ins and outs of monoclonal antibody formulation
  • A typical timeline for Investigational New Drug (IND) and Biological License Application (BLA) filings
  • Storage conditions and how they affect mAb stability

Access this eBook for FREE Now!

I have fully read, understood and agree to NanoTemper's Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.